Evidence map›Paper›PMID 31673897›Full record

ArticleJournal of neuro-oncology2019

Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.

Elena Trisolini, Dounia El Wardighi, Marine Giry, Priscilla Bernardi, Renzo Luciano Boldorini, Karima Mokhtari, Marc Sanson

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Molecular features in gangliogliomas: a systematic review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. IDH-mutant gliomas with additional class-defining molecular events.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Elena TrisoliniDepartment of Health Sciences, Università del Piemonte Orientale, 28100, Novara, Italy.
Dounia El WardighiSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau Et de La Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France.
Marine GirySorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau Et de La Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France.
Priscilla BernardiDepartment of Health Sciences, Università del Piemonte Orientale, 28100, Novara, Italy.
Renzo Luciano BoldoriniDepartment of Health Sciences, Università del Piemonte Orientale, 28100, Novara, Italy.
Karima MokhtariAP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Laboratoire de Neuropathologie R Escourolle, AP-HP, Groupe Hospitalier Pitié Salpêtrière, 75013, Paris, France.
Marc SansonSorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau Et de La Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, 75013, Paris, France. marc.sanson@aphp.fr.ORCID http://orcid.org/0000-0002-1813-8476
Centre National de la Recherche Scientifique · FRUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITSorbonne Université · FR

Funding

Ligue Contre le Cancer Equipe labelisée IQ-1548
6 · The paper itself

Abstract

purposeCircumscribed gliomas -pilocytic astrocytomas (PA), gangliogliomas (GG), ependymomas (EP)- are mostly low-grade tumours but may progress to anaplasia and sometimes surgery can be challenging due to deep anatomical localization. Because of the high frequency of MAPK-pathway alterations and availability of targeted therapies for FGFR1 and BRAF-mutated tumors, we investigated these mutational hotspots in a cohort of adult circumscribed gliomas.

methodsAdult patients (>15 years) with diagnosis of PA, GG, EP and DNET were retrospectively identified from two institutions databases. Genomic DNA was extracted from formalin-fixed paraffin-embedded or frozen samples and exons including codons 546 and 656 of FGFR1 and V600 of BRAF were sequenced.

resultsFGFR1 mutations were identified in 15/108 PA and were particularly frequent in optic pathway (6/9 vs. 9/108; p = 10

conclusionsWe report actionable targets, including frequent FGFR1 mutation in optic-pathway PA that makes them excellent candidates to anti-FGFR therapies, and BRAF non-canonical mutations in PA.

Indexed as

AdolescentAdultAgedAged, 80 and overAstrocytomaBrain NeoplasmsEpendymomaFemaleGangliogliomaGliomaHumansMaleMiddle AgedMutationNeoplasms, NeuroepithelialProto-Oncogene Proteins B-rafBRAF protein, humanFGFR1 protein, humanProto-Oncogene Proteins B-rafReceptor, Fibroblast Growth Factor, Type 1BRAFCircumscribed gliomasFGFR1Pilocytic astrocytomas

Identifiers

PMID31673897
OpenAlexW2988468540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.